Financhill
Back

Immunome, Inc. Stock Predictions

Immunome, Inc. Stock Forecast

  • Over the next 52 weeks, Immunome, Inc. has on average historically risen by 59.8% based on the past 5 years of stock performance.
  • Immunome, Inc. has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is Immunome, Inc. Stock Undervalued?
    The current Immunome, Inc. [IMNM] share price is $21.71. The Score for IMNM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • IMNM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Immunome, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Immunome, Inc. has on average historically risen by 59.8% based on the past 5 years of stock performance.

Immunome, Inc. Stock Rating

Buy
63
Immunome, Inc. (IMNM) is a Buy

Is Immunome, Inc. overpriced?

  • Immunome, Inc. has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Immunome, Inc. Stock Price History

Is IMNM stock going to rise?

  • The current trend is moderately bullish and IMNM is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunome.com

52-Week Data

52-Week High:
25.30
52-Week Low:
5.15

Prediction Charts

Market Cap:
2B
Price in USD:
21.71
Volume:
1M
Beta:
1.96

Technical Analysis

SMA50:
18.17
SMA100:
14.48
SMA200:
11.54
52-Wk Change:
95.59%

Stock Predictions

  • Is Immunome, Inc. stock public?
    Yes, Immunome, Inc. is a publicly traded company.
  • What is the Immunome, Inc. stock quote today?
    The Immunome, Inc. stock price is 21.71 USD today.
  • How to buy Immunome, Inc. stock online?
    You can buy Immunome, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-8 20.13 19.64 20.39 19.29
Dec-9 19.58 19.06 19.91 19.03
Dec-10 19.10 20.30 20.44 18.87
Dec-11 20.20 19.49 20.80 19.27
Dec-12 19.67 19.57 19.82 18.81
Dec-15 22.92 22.64 25.30 21.22
Dec-16 22.88 23.48 24.07 22.60
Dec-17 21.60 19.78 21.93 19.77
Dec-18 20.19 19.95 20.50 19.37
Dec-19 20.71 21.44 21.99 20.18
Dec-22 21.96 22.03 22.39 21.23
Dec-23 21.90 21.73 22.45 21.44
Dec-24 21.70 22.33 22.53 21.56
Dec-26 22.01 21.71 22.16 21.33

Immunome, Inc. Earnings

Immunome, Inc. Earnings Report: Per Share Immunome, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunome, Inc. Forecast Revenue Growth

Immunome, Inc. Stock Analysis: Historical quarterly revenues per share for Immunome, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.95 per share, and a decrease next year of $0.36 per share.

* Immunome, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.